BLS Polymers IPO GMP Today: Latest GMP, Expected Listing Price, Dates and Review

Quick Answer: BLS Polymers IPO GMP is reported at ₹40 on 27 October 2026, implying an estimated listing price of ₹190 against the upper issue price of ₹150. The IPO is open from 27 to 29 October 2026, with a tentative listing date of 3 November 2026

BLS Polymers IPO GMP today is ₹40 as of 27 October 2026, according to the latest reported grey market data. With an IPO price band of ₹142 to ₹150 per share, this premium indicates an estimated listing price of ₹190 per share, or a potential gain of 26.67% over the upper price band. However, grey market premiums are unofficial and do not guarantee listing gains.

The BLS Polymers IPO opened for subscription on 27 October 2026 and will close on 29 October 2026. The company aims to raise ₹255 crore through a fresh issue of shares. Investors should assess the company’s financial performance, valuation, business prospects and IPO demand before making an investment decision.

BLS Polymers IPO GMP Today

As of 27 October 2026, the reported grey market premium for BLS Polymers IPO is ₹40 per share.

Source: IPO market reports and issue details available on 27 October 2026. GMP may change during the subscription period.

BLS Polymers IPO GMP Trend

The grey market premium provides an unofficial indication of investor sentiment before an IPO lists on the stock exchanges. Recent reported data shows that the premium has increased from ₹30 to ₹40 over the past week.

Historical GMP figures are indicative reported observations, not official exchange prices. Different trackers may show different values depending on the time of their updates.

The recent rise in GMP suggests improving sentiment in the unofficial market. Nevertheless, the premium can decline before listing, and actual share prices may differ significantly from these estimates.

BLS Polymers IPO Expected Listing Price

The expected listing price can be estimated by adding the reported GMP to the upper end of the IPO price band.

Formula:

Estimated listing price = Upper IPO price band + GMP

= ₹150 + ₹40

= ₹190 per share

The implied listing gain is calculated as:

[
\frac{190-150}{150}\times100=26.67%
]

Based on this estimate, an investor applying for one lot of 100 shares at ₹150 per share would invest ₹15,000. If the shares list at ₹190, the estimated value would be ₹19,000, representing a notional gain of ₹4,000 before applicable charges and taxes.

This is a hypothetical calculation, not a prediction or guaranteed return. The actual listing price could be higher or lower.

BLS Polymers IPO Subscription Status

The IPO opened on 27 October 2026 and will remain open until 29 October 2026.

Investors should check the latest category-wise subscription figures for retail individual investors, non-institutional investors and qualified institutional buyers before making a decision.

Subscription figures can change throughout the bidding period. The final demand for the issue, particularly from institutional investors, may provide additional information about investor interest.

Note: Check a live IPO tracker or the official exchange disclosures for the latest subscription status rather than relying on outdated figures.

BLS Polymers IPO Details

BLS Polymers is launching a ₹255 crore book-built IPO consisting entirely of a fresh issue of approximately 1.70 crore equity shares.

The IPO proceeds are intended to support manufacturing expansion at the company’s Goa facility, meet working capital requirements and fund general corporate purposes.

About BLS Polymers Limited

BLS Polymers manufactures specialised polymer compounds used in industrial and infrastructure applications. Its products are used in wire and cable insulation and sheathing, as well as protective coatings for underground oil, gas and water pipelines.

The company’s product portfolio includes polymer compounds used across sectors such as power, telecommunications, railways and infrastructure.

Manufacturing capacity, product quality, customer relationships and demand from industrial end-use sectors are important factors to consider when evaluating the company’s long-term prospects.

BLS Polymers Financial Performance

The company’s reported financial results show growth in revenue and profitability during FY2026.

Revenue increased by approximately 6.4% year-on-year, while net profit grew by approximately 27.8%.

These results indicate that profit growth was faster than revenue growth during the reported period. However, investors should also examine operating margins, cash flows, debt, working capital requirements and the company’s valuation before assessing whether the IPO is attractively priced.

BLS Polymers IPO: Should You Apply?

The reported GMP of ₹40 suggests positive unofficial-market sentiment, but it should not be the sole reason to apply.

Factors that may support investor interest

• Growing profitability: FY2026 net profit increased compared with FY2025.

• Industrial demand exposure: The company’s products serve power, telecommunications, railway and pipeline infrastructure applications.

• Manufacturing expansion: A portion of the IPO proceeds is earmarked for expanding production capacity.

Risks investors should consider

• GMP uncertainty: The unofficial premium may change sharply before listing.

• Working capital requirements: A significant portion of the proceeds is intended for working capital.

• Execution risk: Planned capacity expansion must translate into sustainable sales and profitability.

• Valuation risk: Strong reported growth does not automatically mean the IPO price is attractive.

• Listing volatility: The actual listing price may be below the issue price, resulting in a loss.

Investors should read the company’s Red Herring Prospectus (RHP), including its risk factors, financial statements and objects of the issue, before applying.

BLS Polymers IPO Important Dates

Dates are tentative where indicated and may be subject to official updates.

Frequently Asked Questions

1. What is BLS Polymers IPO GMP today?

BLS Polymers IPO GMP is reported at ₹40 per share on 27 October 2026. The premium is unofficial and may change during the day.

2. What is the expected listing price of BLS Polymers IPO?

Based on a ₹150 upper price band and ₹40 GMP, the estimated listing price is ₹190 per share. This estimate does not guarantee the actual listing price.

3. What is the expected listing gain for BLS Polymers IPO?

The implied gain is approximately 26.67% over the upper price band of ₹150, based on the reported GMP of ₹40.

4. What is the BLS Polymers IPO price band?

The IPO price band is ₹142 to ₹150 per equity share.

5. What is the minimum investment in BLS Polymers IPO?

The minimum application is for 100 shares. At the upper price band of ₹150, the investment amount is ₹15,000, excluding any applicable charges.

6. When will BLS Polymers IPO allotment be finalised?

The allotment is expected to be finalised on 30 October 2026.

7. When will BLS Polymers IPO list on the stock exchanges?

The tentative listing date is 3 November 2026 on NSE and BSE.

8. Is BLS Polymers IPO GMP reliable?

No. GMP is an unofficial market indicator, not a regulated exchange price. It may not reflect the actual demand or listing price, so investors should not rely on it alone.

9. Is BLS Polymers IPO worth applying for?

The decision depends on the investor’s risk tolerance, investment horizon, valuation assessment and view of the company’s business prospects. A high GMP alone is insufficient to establish whether an IPO is worth applying for.

Conclusion

BLS Polymers IPO GMP today stands at a reported ₹40 as of 27 October 2026, implying an estimated listing price of ₹190 and a potential gain of 26.67% over the upper issue price. The company reported growth in revenue and profit in FY2026 and plans to use IPO proceeds for manufacturing expansion and working capital.

However, the actual listing performance will depend on market conditions, investor demand, valuation and business fundamentals. Investors should verify the latest GMP and subscription figures and review the RHP Draft Prospectus and DRHP Draft Prospectus before making an investment decision.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. IPO GMP figures are unofficial, can change without notice and do not guarantee listing gains. Investors should conduct their own research or consult a SEBI-registered investment adviser before investing.